ConductScience.org, home

Paper8760804

The natural killer cell receptor specific for HLA-A allotypes: a novel member of the p58/p70 family of inhibitory receptors that is characterized by three immunoglobulin-like domains and is expressed as a 140-kD disulphide-linked dimer.

Pende D and 9 others. J Exp Med, 1996. Cited by 314 papers, by iCite.

Cite this record

ConductScience Library. The natural killer cell receptor specific for HLA-A allotypes: a novel member of the p58/p70 family of inhibitory receptors that is characterized by three immunoglobulin-like domains and is expressed as a 140-kD disulphide-linked dimer. Papers, record 8760804. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/8760804

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
The natural killer cell receptor specific for HLA-A allotypes: a novel member of the p58/p70 family of inhibitory receptors that is characterized by three immunoglobulin-like domains and is expressed as a 140-kD disulphide-linked dimer.
PubMed
Journal
J Exp Med
PubMed
Year
1996
PubMed
Publication types
Journal Article, Research Support, Non-U.S. Gov't
PubMed
Citations, by iCite
314
iCite
Relative citation ratio, by iCite
6.32
iCite
Revised in PubMed
2022-03-18
PubMed

Authors10

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Pende DD
2Biassoni RR
3Cantoni CC
4Verdiani SS
5Falco MM
6di Donato CC
7Accame LL
8Bottino CC
9Moretta AA
10Moretta LL

Source PubMed

Download CSV of authors

Topics18

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
HLA-A3 AntigenMajor topic
Killer Cells, NaturalMajor topic
Receptors, ImmunologicMajor topic
3T3 Cells
Amino Acid Sequence
Animals
Antibodies, Monoclonal
Base Sequence
Cloning, Molecular
DNA Primers
DNA, Complementary
Disulfides
Humans
Macromolecular Substances
Mice
Molecular Sequence Data
Receptors, KIR
Receptors, KIR2DL3

Source PubMed

Download CSV of topics

References29

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
18149950Self class I molecules protect normal cells from lysis mediated by autologous natural killer cells.Eur J Immunol1994https://conductscience.org/library/papers/8149950PubMed
28376937Specificity of HLA class I antigen recognition by human NK clones: evidence for clonal heterogeneity, protection by self and non-self alleles, and influence of the target cell type.J Exp Med1993https://conductscience.org/library/papers/8376937PubMed
38046333Human natural killer cell receptors for HLA-class I molecules. Evidence that the Kp43 (CD94) molecule functions as receptor for HLA-B alleles.J Exp Med1994https://conductscience.org/library/papers/8046333PubMed
47925558T cell clones expressing the natural killer cell-related p58 receptor molecule display heterogeneity in phenotypic properties and p58 function.Eur J Immunol1994https://conductscience.org/library/papers/7925558PubMed
57523145
The human natural killer cell receptor for major histocompatibility complex class I molecules. Surface modulation of p58 molecules and their linkage to CD3 zeta chain, Fc epsilon RI gamma chain and the p56lck kinase.
Eur J Immunol1994https://conductscience.org/library/papers/7523145PubMed
67716542Superantigen-dependent, cell-mediated cytotoxicity inhibited by MHC class I receptors on T lymphocytes.Science1995https://conductscience.org/library/papers/7716542PubMed
77716543Cloning of immunoglobulin-superfamily members associated with HLA-C and HLA-B recognition by human natural killer cells.Science1995https://conductscience.org/library/papers/7716543PubMed
87749980Molecular clones of the p58 NK cell receptor reveal immunoglobulin-related molecules with diversity in both the extra- and intracellular domains.Immunity1995https://conductscience.org/library/papers/7749980PubMed
97629517
Amino acid substitutions can influence the natural killer (NK)-mediated recognition of HLA-C molecules. Role of serine-77 and lysine-80 in the target cell protection from lysis mediated by "group 2" or "group 1" NK clones.
J Exp Med1995https://conductscience.org/library/papers/7629517PubMed
107650366Molecular cloning of NKB1. A natural killer cell receptor for HLA-B allotypes.J Immunol1995https://conductscience.org/library/papers/7650366PubMed
117650491Existence of both inhibitory (p58) and activatory (p50) receptors for HLA-C molecules in human natural killer cells.J Exp Med1995https://conductscience.org/library/papers/7650491PubMed
127589107Molecular characterization of human CD94: a type II membrane glycoprotein related to the C-type lectin superfamily.Eur J Immunol1995https://conductscience.org/library/papers/7589107PubMed
137547697
Cytolytic T lymphocytes displaying natural killer (NK)-like activity: expression of NK-related functional receptors for HLA class I molecules (p58 and CD94) and inhibitory effect on the TCR-mediated target cell lysis or lymphokine production.
Int Immunol1995https://conductscience.org/library/papers/7547697PubMed
148627176
The human leukocyte antigen (HLA)-C-specific "activatory" or "inhibitory" natural killer cell receptors display highly homologous extracellular domains but differ in their transmembrane and intracytoplasmic portions.
J Exp Med1996https://conductscience.org/library/papers/8627176PubMed
158643653Physical and functional independency of p70 and p58 natural killer (NK) cell receptors for HLA class I: their role in the definition of different groups of alloreactive NK cell clones.Proc Natl Acad Sci U S A1996https://conductscience.org/library/papers/8643653PubMed
168717527Receptors for HLA class-I molecules in human natural killer cells.Annu Rev Immunol1996https://conductscience.org/library/papers/8717527PubMed
172461560Rapid production of full-length cDNAs from rare transcripts: amplification using a single gene-specific oligonucleotide primer.Proc Natl Acad Sci U S A1988https://conductscience.org/library/papers/2461560PubMed
182683611Biology of natural killer cells.Adv Immunol1989https://conductscience.org/library/papers/2683611PubMed
192137855A novel surface antigen expressed by a subset of human CD3- CD16+ natural killer cells. Role in cell activation and regulation of cytolytic function.J Exp Med1990https://conductscience.org/library/papers/2137855PubMed
201694227Specific recognition of human CD3-CD16+ natural killer cells requires the expression of an autosomic recessive gene on target cells.J Exp Med1990https://conductscience.org/library/papers/1694227PubMed

See all 29 referencesDownload CSV of references

Cited by85

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 314 citations.

PMIDTitleJournalYearIn PapersSource
41188903Leveraging the heterogeneity of the NK cell repertoire for the development of immunotherapies for acute leukemia.J Transl Med2025https://conductscience.org/library/papers/41188903PubMed
39262781Exploring the role of KIR3DL2 on NK cells in hepatocellular carcinoma and its potential prognostic implications.iScience2024https://conductscience.org/library/papers/39262781PubMed
35911762Host KIR/HLA-C Genotypes Determine HIV-Mediated Changes of the NK Cell Repertoire and Are Associated With Vpu Sequence Variations Impacting Downmodulation of HLA-C.Front Immunol2022https://conductscience.org/library/papers/35911762PubMed
35095867KIR-HLA Functional Repertoire Influences Trastuzumab Efficiency in Patients With HER2-Positive Breast Cancer.Front Immunol2021https://conductscience.org/library/papers/35095867PubMed
34760351Abundant CpG-sequences in human genomes inhibit KIR3DL2-expressing NK cells.PeerJ2021https://conductscience.org/library/papers/34760351PubMed
34272304Individualized genetic makeup that controls natural killer cell function influences the efficacy of isatuximab immunotherapy in patients with multiple myeloma.J Immunother Cancer2021https://conductscience.org/library/papers/34272304PubMed
32804949Epistatic interactions between killer immunoglobulin-like receptors and human leukocyte antigen ligands are associated with ankylosing spondylitis.PLoS Genet2020https://conductscience.org/library/papers/32804949PubMed
32213565Two Lineages of KLRA with Contrasting Transcription Patterns Have Been Conserved at a Single Locus during Ruminant Speciation.J Immunol2020https://conductscience.org/library/papers/32213565PubMed
31337191
Certain Killer Immunoglobulin-Like Receptor (KIR)/KIR HLA Class I Ligand Genotypes Influence Natural Killer Antitumor Activity in Myelogenous Leukemia but Not in Acute Lymphoblastic Leukemia: A Case Control Leukemia Association Study
Turk J Haematol2019https://conductscience.org/library/papers/31337191PubMed
31231370Killer Ig-Like Receptors (KIRs): Their Role in NK Cell Modulation and Developments Leading to Their Clinical Exploitation.Front Immunol2019https://conductscience.org/library/papers/31231370PubMed
29930758Prognostic values of the mRNA expression of natural killer receptor ligands and their association with clinicopathological features in breast cancer patients.Oncotarget2018https://conductscience.org/library/papers/29930758PubMed
29358179Strategies to activate NK cells to prevent relapse and induce remission following hematopoietic stem cell transplantation.Blood2018https://conductscience.org/library/papers/29358179PubMed
29263215Human NK Cells Downregulate Zap70 and Syk in Response to Prolonged Activation or DNA Damage.J Immunol2018https://conductscience.org/library/papers/29263215PubMed
29032460The impact of KIR-HLA genotype on hepatitis B virus clearance in Iranian infected individuals.Med Microbiol Immunol2017https://conductscience.org/library/papers/29032460PubMed
28912774Therapeutic Antibodies to KIR3DL2 and Other Target Antigens on Cutaneous T-Cell Lymphomas.Front Immunol2017https://conductscience.org/library/papers/28912774PubMed
28659916HLA-Bw4-I-80 Isoform Differentially Influences Clinical Outcome As Compared to HLA-Bw4-T-80 and HLA-A-Bw4 Isoforms in Rituximab or Dinutuximab-Based Cancer Immunotherapy.Front Immunol2017https://conductscience.org/library/papers/28659916PubMed
27490240KIR and HLA Genotypes Implicated in Reduced Killer Lymphocytes Immunity Are Associated with Vogt-Koyanagi-Harada Disease.PLoS One2016https://conductscience.org/library/papers/27490240PubMed
26874942Killer-cell immunoglobulin-like receptor genes and ligands and their role in hematologic malignancies.Cancer Immunol Immunother2016https://conductscience.org/library/papers/26874942PubMed
26013798Practical NK cell phenotyping and variability in healthy adults.Immunol Res2015https://conductscience.org/library/papers/26013798PubMed
25582852The D0 Ig-like domain plays a central role in the stronger binding of KIR3DL2 to B27 free H chain dimers.J Immunol2015https://conductscience.org/library/papers/25582852PubMed

See all 85 cited byDownload CSV of cited by

Genes8

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

GeneNCBI Gene IDLinked byIn GenesSource
KIR3DL13811Swiss-Prot's referenceshttps://conductscience.org/library/genes/3811NCBI Gene
KIR3DL23812Swiss-Prot's referenceshttps://conductscience.org/library/genes/3812NCBI Gene
HLA-A3105PubTator's text mininghttps://conductscience.org/library/genes/3105NCBI Gene
HLA-B3106PubTator's text mininghttps://conductscience.org/library/genes/3106NCBI Gene
HLA-C3107PubTator's text mininghttps://conductscience.org/library/genes/3107NCBI Gene
IGKV3D-2028874PubTator's text mininghttps://conductscience.org/library/genes/28874NCBI Gene
KIR2DL33804PubTator's text mininghttps://conductscience.org/library/genes/3804NCBI Gene
UBASH3B84959PubTator's text mininghttps://conductscience.org/library/genes/84959NCBI Gene

Download CSV of genes

Data5

The data bank entries PubMed's record names. Trial numbers are under Trials.

Data bankAccessionSource
GENBANKX93595GENBANK
GENBANKX93596GENBANK
GENBANKX94262GENBANK
GENBANKX94373GENBANK
GENBANKX94374GENBANK

Download CSV of data

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • Drugs

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/8760804

GET https://conductscience.org/api/papers/v1/8760804/references?page=2